3D Structures of HIV-1 GP120 in PDB

4OLZ: Crystal structure of antibody VRC07-G54W in complex with clade A/E 93TH057 HIV-1 gp120 core
4OLY: Crystal structure of antibody VRC07-G54R in complex with clade A/E 93TH057 HIV-1 gp120 core
4JZW: Crystal structure of CD4-mimetic miniprotein M48U1 in complex with HIV-1 YU2 gp120 in P212121 space group
5CJX: Crystal structure of 8ANC195 Fab in complex with BG505 SOSIP.664 HIV-1 Env trimer
5I9Q: Crystal structure of 3BNC55 Fab in complex with 426c.TM4deltaV1-3 gp120
4OLX: Crystal structure of antibody VRC07-G54L in complex with clade A/E 93TH057 HIV-1 gp120 core
5U1F: CryoEM structure of BG505 DS SOSIP trimer in complex with CD4 and PGT145
4JZZ: Crystal structure of CD4-mimetic miniprotein M48U1 in complex with HIV-1 YU2 gp120 in C2221 space group
4OLW: Crystal structure of antibody VRC07-G54H in complex with clade A/E 93TH057 HIV-1 gp120 core
4YE4: Crystal Structure of Neutralizing Antibody HJ16 in Complex with HIV-1 gp120
1SZT: ATOMIC STRUCTURE OF A THERMOSTABLE SUBDOMAIN OF HIV-1 GP41
4OLV: Crystal structure of antibody VRC07-G54F in complex with clade A/E 93TH057 HIV-1 gp120 core
4OLU: Crystal structure of antibody VRC07 in complex with clade A/E 93TH057 HIV-1 gp120 core
4YDI: Crystal structure of broad and potently neutralizing VRC01-class antibody Z258-VRC27.01, isolated from human donor Z258, in complex with HIV-1 gp120 from clade A strain Q23.17
4YDJ: Crystal structure of broadly and potently neutralizing antibody 44-VRC13.01 in complex with HIV-1 clade AE strain 93TH057 gp120
5F96: Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235.12 in complex with HIV-1 clade A/E 93TH057 gp120
1TJH: Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 11mer epitope
4YDK: Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120
1TJG: Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 7mer epitope
4YDL: Crystal structure of broadly and potently neutralizing antibody C38-VRC18.02 in complex with HIV-1 clade AE strain 93TH057gp120
1TJI: Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 17mer epitope
4RIS: Structural Analysis of the Unmutated Ancestor of the HIV-1 Envelope V2 Region Antibody CH58 Isolated From an RV144 HIV-1 Vaccine Efficacy Trial Vaccinee and Associated with Decreased Transmission Risk
3ECB: Crystal structure of mouse H-2Dd in complex with peptide P18-I10 derived from human immunodeficiency virus envelope glycoprotein 120
3VIE: HIV-gp41 fusion inhibitor Sifuvirtide
3H01: Structure of the C-terminal Domain of a Putative HIV-1 gp41 Fusion Intermediate
3GO1: Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN
5UTY: Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, N300M, N302M, T320L in Complex with Human Antibodies PGT122 and 35O22 at 4.1 Angstrom
3IDY: Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C2221
3H00: Structure of the C-terminal Domain of a Putative HIV-1 gp41 Fusion Intermediate
3IDX: Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C222
3J70: Model of gp120, including variable regions, in complex with CD4 and 17b
5I8H: Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting Antibody PGT122 Fab and Fusion Peptide-targeting Antibody VRC34.01 Fab
5KJR: Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1.
5A7X: negative stain EM of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195
5GHW: Crystal structure of broad neutralizing antibody 10E8 with long epitope bound
5V7J: Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22.
1B03: SOLUTION STRUCTURE OF THE ANTIBODY-BOUND HIV-1IIIB V3 PEPTIDE
4RFN: Crystal structure of ADCC-potent Rhesus macaque ANTIBODY JR4 in complex with HIV-1 CLADE A/E GP120 and M48
4RFO: Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and M48u1
4ZTO: Fab/epitope complex structure of rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region
4OM0: Crystal structure of antibody VRC07-G54Y in complex with clade A/E 93TH057 HIV-1 gp120 core
5F9W: Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235 in complex with HIV-1 clade A/E 93TH057 gp120
4OM1: Crystal structure of antibody VRC07-I30Q, G54W, S58N in complex with clade A/E 93TH057 HIV-1 gp120 core
5A8H: cryo-ET subtomogram averaging of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195
5C7K: Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT128 and 8ANC195
5F9O: Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235.09 in complex with HIV-1 clade A/E 93TH057 gp120
2NY7: HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12
2NY6: HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b
2NY5: HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b
2NXZ: HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b
4R4H: Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120
2NXY: HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b
4R4F: Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120
2NY0: HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b
4XMP: Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clade A strain Q842.d12 gp120
4YC2: Crystal structure of the stabilized inner domain of clade A/E HIV-1 gp120 from E. coli in complex with the antibody A32.
4LAJ: Crystal structure of HIV-1 YU2 envelope gp120 glycoprotein in complex with CD4-mimetic miniprotein, M48U1, and llama single-domain, broadly neutralizing, co-receptor binding site antibody, JM4
2NY4: HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b
2NY3: HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b
4XMK: Crystal structure of Fab of HIV-1 gp120 V3-specific human monoclonal antibody 2424 in complex with JR-FL V3 peptide
2NY2: HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b
4JKP: Restricting HIV-1 Pathways for Escape using Rationally-Designed Anti-HIV-1 Antibodies
2NY1: HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b
4R4N: Crystal structure of the anti-hiv-1 antibody 2.2c in complex with hiv-1 93ug037 gp120
4RZ8: Crystal structure of HIV-1 gp120 core in complex with NBD-11021, a small molecule CD4-antagonist
3U2S: Crystal Structure of PG9 Fab in Complex with V1V2 Region from HIV-1 strain ZM109
4YBL: Crystal structure of the stabilized inner domain of clade A/E HIV-1 gp120 in complex with the ADCC mediating ANTI-HIV-1 antibody A32
4LSS: Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 clade A strain KER_2018_11 gp120
4LST: Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 clade C strain ZM176.66 gp120
4LSU: Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clade A/E 93TH057 gp120
4LSV: Crystal structure of broadly and potently neutralizing antibody 3BNC117 in complex with HIV-1 clade C C1086 gp120
4LSP: Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057
4LSQ: Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057 with LOOP D and Loop V5 from clade A strain 3415_v1_c1
5FUU: Ectodomain of cleaved wild type JR-FL EnvdCT trimer in complex with PGT151 Fab
4LSR: Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E stran 93TH057 gp120 with LOOP D and Loop V5 from clade A strain KER_2018_11
2CMR: CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
1QNZ: NMR structure of the 0.5b anti-HIV antibody complex with the gp120 V3 peptide
5IGX: Crystal structure of NIH45-46 Fab germline precursor in complex with 426c.TM1deltaV1-3 gp120
4XNY: Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade A strain Q842.d12 gp120
5UTF: Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M in Complex with Human Antibodies PGT122 and 35O22 at 4.3 A
4RWY: Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 8ANC131 in complex with HIV-1 clade B YU2 gp120
3VH7: Structure of HIV-1 gp41 NHR/fusion inhibitor complex P21
5D9Q: Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizing Fab PGT122 and scFv NIH45-46
3VGY: Structure of HIV-1 gp41 NHR/fusion inhibitor complex P321
3VGX: Structure of gp41 T21/Cp621-652
3NGB: Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 gp120
2F5B: CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
4XNZ: Crystal structure of broadly and potently neutralizing antibody VRC06B in complex with HIV-1 clade A/E strain 93TH057 gp120
3JWD: Structure of HIV-1 gp120 with gp41-Interactive Region: Layered Architecture and Basis of Conformational Mobility
5F4U: HIV-1 gp120 complex with BNM-IV-197
5ESV: Crystal Structure of Broadly Neutralizing Antibody CH03, Isolated from Donor CH0219, in Complex with Scaffolded Trimeric HIV-1 Env V1V2 Domain from the Clade C Superinfecting Strain of Donor CAP256.
4I48: Structure of HLA-A68 complexed with an HIV Env derived peptide
5ESZ: Crystal Structure of Broadly Neutralizing Antibody CH04, Isolated from Donor CH0219, in Complex with Scaffolded Trimeric HIV-1 Env V1V2 Domain from the Clade AE Strain A244
4R2G: Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4
4I3S: Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P21
4I3R: Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221
1U6V: NMR structure of a V3 (IIIB isolate) peptide bound to 447-52D, a human HIV-1 neutralizing antibody
1U6U: NMR structure of a V3 (IIIB isolate) peptide bound to 447-52D, a human HIV-1 neutralizing antibody
5F4L: HIV-1 gp120 complex with JP-III-048
5F4R: HIV-1 gp120 complex with BNW-IV-147
5F4P: HIV-1 gp120 complex with BNM-III-170
3SE8: Crystal structure of broadly and potently neutralizing antibody VRC03 in complex with HIV-1 gp120
2I5Y: Crystal structure of CD4M47, a scorpion-toxin mimic of CD4, in complex with HIV-1 YU2 GP120 envelope glycoprotein and anti-HIV-1 antibody 17B
4JM2: Crystal Structure of PGT 135 Fab in Complex with gp120 Core Protein from HIV-1 Strain JR-FL Bound to CD4 and 17b Fab
3SE9: Crystal structure of broadly and potently neutralizing antibody VRC-PG04 in complex with HIV-1 gp120
4I53: Crystal structure of clade C1086 HIV-1 gp120 core in complex with DMJ-II-121
1MEQ: HIV gp120 C5
2I60: Crystal structure of [Phe23]M47, a scorpion-toxin mimic of CD4, in complex with HIV-1 YU2 GP120 envelope glycoprotein and anti-HIV-1 antibody 17B
4I54: Crystal structure of clade A/E 93TH057 HIV-1 gp120 H375S core in complex with DMJ-II-121
3U4E: Crystal Structure of PG9 Fab in Complex with V1V2 Region from HIV-1 strain CAP45
2X4O: CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128
5FEC: Crystal structure of 3BNC60 Fab germline precursor in complex with 426c.TM4deltaV1-3 gp120
4KA2: Crystal structure of CD4-mimetic miniprotein M48U12 in complex with HIV-1 YU2 gp120
1U6A: Crystal Structure of the Broadly Neutralizing Anti-HIV Fab F105
5VIY: BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195
5FYJ: Crystal Structure at 3.4 A Resolution of Fully Glycosylated HIV-1 Clade G X1193.c1 SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122, 35O22 and VRC01
5V8M: A broadly neutralizing antibody targets the dynamic HIV Envelope trimer apex via a long, rigidified, and anionic beta-hairpin structure
5FYK: Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade B JR-FL SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122, 35O22 and VRC01
5V8L: BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145
3JCC: Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 36D5
4HPY: Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide
3JCB: Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 36D5
5FYL: Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122 and 35O22
2ME2: HIV-1 gp41 clade C Membrane Proximal External Region peptide in DPC micelle
2ME3: HIV-1 gp41 clade C Membrane Proximal External Region peptide in DPC micelle
2ME4: HIV-1 gp41 clade C Membrane Proximal External Region peptide in DPC micelle
4HPO: Crystal structure of RV144-elicited antibody CH58 in complex with V2 peptide
3RU8: Structure of an HIV epitope scaffold in complex with neutralizing antibody b12 Fab
3WFV: HIV-1 CRF07 gp41
5IVX: Crystal Structure of B4.2.3 T-Cell Receptor and H2-Dd P18-I10 Complex
3J5M: Cryo-EM structure of the BG505 SOSIP.664 HIV-1 Env trimer with 3 PGV04 Fabs
5F6J: Crystal Structure of Tier 2 Neutralizing Antibody DH427 from a Rhesus Macaque in Complex with HIV-1 gp120 Core
2X7R: CRYSTAL STRUCTURE OF A LATE FUSION INTERMEDIATE OF HIV-1 GP41
4K0A: Crystal structure of CD4-mimetic miniprotein M48U7 in complex with HIV-1 YU2 gp120
5VJ6: BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195
2PV6: HIV-1 gp41 Membrane Proximal Ectodomain Region peptide in DPC micelle
3VTQ: Novel HIV fusion inhibitor
4J6R: Crystal structure of broadly and potently neutralizing antibody VRC23 in complex with HIV-1 gp120
4JO3: Crystal structure of rabbit mAb R20 Fab in complex with V3 C-terminus of HIV-1 Consensus B gp120
4JO1: Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 JR-FL gp120
1NIZ: NMR structure of a V3 (MN isolate) peptide bound to 447-52D, a human HIV-1 neutralizing antibody
4JO2: Crystal structure of rabbit mAb R56 Fab in complex with V3 crown of HIV-1 Consensus A gp120
1NJ0: NMR structure of a V3 (MN isolate) peptide bound to 447-52D, a human HIV-1 neutralizing antibody
5IDL: Crystal structure of the germline-targeting HIV-1 gp120 engineered outer domain, eOD-GT8
1YYM: crystal structure of F23, a scorpion-toxin mimic of CD4, in complex with HIV-1 YU2 gp120 envelope glycoprotein and anti-HIV-1 antibody 17b
5JYN: Structure of the transmembrane domain of HIV-1 gp41 in bicelle
5ACO: Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer
1YYL: crystal structure of CD4M33, a scorpion-toxin mimic of CD4, in complex with HIV-1 YU2 gp120 envelope glycoprotein and anti-HIV-1 antibody 17b
5THR: Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex
5UM8: Crystal structure of HIV-1 envelope trimer 16055 NFL TD CC (T569G) in complex with Fabs 35022 and PGT124
1RZJ: HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1RZK: HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
5TE4: Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade G Strain X2088 gp120 Core
5TE6: Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade AE Strain 93TH057 gp120 Core
5TE7: Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade C Strain DU172.17 gp120 Core
1CE4: CONFORMATIONAL MODEL FOR THE CONSENSUS V3 LOOP OF THE ENVELOPE PROTEIN GP120 OF HIV-1
2B1H: Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG29 peptide
2B1A: Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG1033 peptide
3GWO: Structure of the C-terminal Domain of a Putative HIV-1 gp41 Fusion Intermediate
5T3X: 3.9 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trimer in Complex with the Broadly Neutralizing Antibodies IOMA and 10-1074.
5T3Z: 3.5 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trimer in Complex with the Broadly Neutralizing Antibodies IOMA and 10-1074
2QSC: Crystal structure analysis of anti-HIV-1 V3-Fab F425-B4e8 in complex with a V3-peptide
3U7Y: Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV
5JS9: Uncleaved prefusion optimized gp140 trimer with an engineered 8-residue HR1 turn bound to broadly neutralizing antibodies 8ANC195 and PGT128
5BN0: A new HIV fusion peptide inhibitor
1P5A: Conformational Mapping of the N-terminal Peptide of HIV-1 GP41 in lipid detergent and aqueous environments using 13C-enhanced Fourier Transform Infrared Spectroscopy
3TIH: Crystal structure of unliganded HIV-1 clade C strain ZM109F.PB4 gp120 core
3MLV: Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with an NOF V3 peptide
4JPK: Crystal structure of the germline-targeting HIV-1 gp120 engineered outer domain eOD-GT6 in complex with a putative VRC01 germline precursor Fab
4JPJ: Crystal structure of the germline-targeting HIV-1 gp120 engineered outer domain, eOD-GT6
3MLY: Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a UR29 V3 peptide
3MLR: Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with a NY5 V3 peptide
3MLT: Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with a UG1033 V3 peptide
3MLU: Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with a ZAM18 V3 peptide
3MLZ: Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide
1DF5: INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION
4JPW: Crystal structure of broadly and potently neutralizing antibody 12a21 in complex with hiv-1 strain 93th057 gp120 mutant
4JPV: Crystal structure of broadly and potently neutralizing antibody 3bnc117 in complex with hiv-1 gp120
1DF4: INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION
4JAN: crystal structure of broadly neutralizing antibody CH103 in complex with HIV-1 gp120
3UJJ: Crystal structure of anti-HIV-1 V3 Fab 4025 in complex with Con A peptide
3FN0: Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41
1GC1: HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
4ZMJ: Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer
5FCU: CRYSTAL STRUCTURE OF THE INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4
3HI1: Structure of HIV-1 gp120 (core with V3) in Complex with CD4-Binding-Site Antibody F105
2B4C: Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) complexed with CD4 and the X5 antibody
4DVX: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with MAE-II-188
4JB9: Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core
4DVW: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with MAE-II-167
4DVV: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AS-I-261
4DVT: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AS-II-37
4DVR: Crystal structure of YU2 gp120 core in complex with Fab 48d and NBD-557
4DVS: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with NBD-557
2ARI: Solution structure of micelle-bound fusion domain of HIV-1 gp41
5JSA: Uncleaved prefusion optimized gp140 trimer with an engineered 10-residue HR1 turn bound to broadly neutralizing antibodies 8ANC195 and PGT128
4S1Q: Crystal structure of a VRC01-lineage antibody, 45-VRC01.H03+06.D-001739, in complex with clade A/E HIV-1 gp120 core
1G9M: HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1G9N: HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
2QAD: Structure of tyrosine-sulfated 412d antibody complexed with HIV-1 YU2 gp120 and CD4
2ESX: The structure of the V3 region within gp120 of JR-FL HIV-1 strain (minimized average structure)
5U6E: Crystal structure of clade A/E HIV-1 gp120 core in complex with NBD-14010
3TGQ: Crystal structure of unliganded HIV-1 clade B strain YU2 gp120 core
2ESZ: The structure of the V3 region within gp120 of JR-FL HIV-1 strain (ensemble)
3TGS: Crystal structure of HIV-1 clade C strain C1086 gp120 core in complex with NBD-556
4S1R: Crystal structure of a VRC01-lineage antibody, 45-VRC01.H08.F-117225, in complex with clade A/E HIV-1 gp120 core
3TGR: Crystal structure of unliganded HIV-1 clade C strain C1086 gp120 core
4S1S: Crystal structure of a VRC01-lineage antibody, 45-VRC01.H5.F-185917, in complex with clade A/E HIV-1 gp120 core
3TGT: Crystal structure of unliganded HIV-1 clade A/E strain 93TH057 gp120 core
3DNL: Molecular structure for the HIV-1 gp120 trimer in the b12-bound state
1ACY: CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV-1
5CAY: Envelope glycoprotein gp120 core from HIV type 2 bound to the first two domains of human soluble CD4 receptor
3TYG: Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with a glycosylated engineered gp120 outer domain with miniV3 (eODmV3)
3DNN: Molecular structure for the HIV-1 gp120 trimer in the unliganded state
1HHG: THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
3DNO: Molecular structure for the HIV-1 gp120 trimer in the CD4-bound state
5C0S: Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261
3W19: Potent HIV fusion inhibitor CP32M-2
5C0R: Crystal Structure of a Generation 3 Influenza Hemagglutinin Stabilized Stem Complexed with the Broadly Neutralizing Antibody C179
4XVT: Crystal structure of HIV-1 93TH057 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
3RJQ: Crystal structure of anti-HIV llama VHH antibody A12 in complex with C186 gp120
4DKU: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with NBD-09027
4XVS: Crystal structure of HIV-1 donor 45 d45-01dG5 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
4DKV: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with NBD-10007
5HFM: Gp41-targeting HIV-1 fusion inhibitors with hook-like Ile-Asp-Leu tail
4CC8: Pre-fusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy
4TVP: Crystal Structure of the HIV-1 BG505 SOSIP.664 Env Trimer Ectodomain, Comprising Atomic-Level Definition of Pre-Fusion gp120 and gp41, in Complex with Human Antibodies PGT122 and 35O22
4DKO: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with TS-II-224
4DKP: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AWS-I-50
4DKQ: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with DMJ-I-228
4DKR: Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AWS-I-169
1NAK: IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
5CD5: Crystal structure of an immature VRC01-class antibody DRVIA7 from a Chinese donor bound to clade A/E HIV-1 gp120 core
4YWG: Crystal structure of 830A in complex with V1V2
4P9H: Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2
4JDT: Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 HIV-1
4RX4: Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 8ANC134 in complex with HIV-1 clade A Q842.d12 gp120
2XA3: CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING LLAMA VHH D7 AND ITS MODE OF HIV-1 GP120 INTERACTION
4NCO: Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizing Fab PGT122
1K5M: Crystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop Chimeric Virus MN-III-2
1GGI: CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
4WY7: Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound
5T3S: HIV gp140 trimer MD39-10MUTA in complex with Fabs PGT124 and 35022
5X08: Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound
1GGC: MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
1GGB: MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
5CEZ: Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with an early putative precursor of the PGT121 family at 3.0 Angstrom
4YFL: Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120
2B0S: Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with MN peptide
5T33: Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.
1DLB: HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES